CN Patent

CN105101958B — 治疗肺病状

Assigned to Nusirt Sciences Inc · Expires 2019-05-17 · 7y expired

What this patent protects

本文提供了可用于治疗肺病状的组合物、方法和药剂盒。这样的组合物可以含有与亮氨酸和/或亮氨酸代谢物和白藜芦醇组合的协同量的非特异性磷酸二酯酶抑制剂，如甲基黄嘌呤。

USPTO Abstract

本文提供了可用于治疗肺病状的组合物、方法和药剂盒。这样的组合物可以含有与亮氨酸和/或亮氨酸代谢物和白藜芦醇组合的协同量的非特异性磷酸二酯酶抑制剂，如甲基黄嘌呤。

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN105101958B
Jurisdiction: CN
Classification: —
Expires: 2019-05-17
Drug substance claim: No
Drug product claim: No
Assignee: Nusirt Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.